TYRA BIOSCIENCES, INC.
TYRA
20.39
+0.15
+0.74%
TYRA BIOSCIENCES, INC.
US · TYRA
#3032 by market cap
Listed 2021
20.39
+0.15
+0.74%
Live - 5344 symbols - heartbeat 117s ago
· 2026-10-08 08:21
Pre-market
20.00
-1.91%
After-hours
20.39
0.00%
- Market cap
- 1.40B
- P/E (TTM)i
- -8.53
- P/Bi
- 3.96
- EPSi
- -2.01
- Div yieldi
- 0.00%
- 52W posi
- 26%
Reader sentiment
Are you bullish or bearish on TYRA?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Tyra Biosciences Price Target Cut to $29.00/Share From $30.00 by HC Wainwright & Co.Dow Jones · 2026/9/22
-
Company notice
TYRA BIOSCIENCES, INC. | SCHEDULE 13G: OthersSEC · 2026/9/22
-
Rating change
A Quick Look at Today's Ratings for TYRA BIOSCIENCES, INC.(TYRA.US), With a Forecast Between $39 to $56Market Newswire · 2026/9/8
-
Rating change
Jefferies Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $42Market Newswire · 2026/8/6
-
CCORF Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $50Market Newswire · 2026/9/22
-
Rating change
H.C. Wainwright Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $45Market Newswire · 2026/9/4
-
Rating change
BofA Securities Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Cuts Target Price to $39Market Newswire · 2026/8/11
-
Rating change
JonesTrading Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $56Market Newswire · 2026/9/10
-
Company notice
TYRA BIOSCIENCES, INC. | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.SEC · 2026/9/18
-
Oppenheimer Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Cuts Target Price to $40Market Newswire · 2026/9/22
-
Barclays Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $59Market Newswire · 2026/9/30
-
Company notice
TYRA BIOSCIENCES, INC. | 4: Statement of changes in beneficial ownership of securities-Officer Rueb YuliyaSEC · 2026/9/18
-
Rating change
A Quick Look at Today's Ratings for TYRA BIOSCIENCES, INC.(TYRA.US), With a Forecast Between $30 to $59Market Newswire · 2026/9/10
-
Company notice
TYRA BIOSCIENCES, INC. | 4: Statement of changes in beneficial ownership of securities-Officer Harris ToddSEC · 2026/9/18
-
Rating change
Wedbush Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $53Market Newswire · 2026/8/5
-
Company notice
TYRA BIOSCIENCES, INC. | 4: Statement of changes in beneficial ownership of securities-Officer Fuhrman AlanSEC · 2026/9/18
-
Rating change
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30Benzinga · 2026/9/10
-
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $29Benzinga · 2026/9/22
-
Rating change
H.C. Wainwright Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Cuts Target Price to $29Market Newswire · 2026/9/22
-
Rating change
Raymond James Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $50Market Newswire · 2026/9/24
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 08:21:22 · For reference only, not investment advice and not tailored to your situation.